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Abstract
Background: Caloric restriction (CR) counters deleterious effects of aging and, for most mouse
genotypes, increases mean and maximum lifespan. Previous analyses of microarray data have
identified gene expression responses to CR that are shared among multiple mouse tissues, including
the activation of anti-oxidant, tumor suppressor and anti-inflammatory pathways. These analyses
have provided useful research directions, but have been restricted to a limited number of tissues,
and have focused on individual genes, rather than whole-genome transcriptional networks.
Furthermore, CR is thought to oppose age-associated gene expression patterns, but detailed
statistical investigations of this hypothesis have not been carried out.
Results: Systemic effects of CR and aging were identified by examining transcriptional responses
to CR in 17 mouse tissue types, as well as responses to aging in 22 tissues. CR broadly induced the
expression of genes known to inhibit oxidative stress (e.g., Mt1, Mt2), inflammation (e.g., Nfkbia,
Timp3) and tumorigenesis (e.g., Txnip, Zbtb16). Additionally, a network-based investigation revealed
that CR regulates a large co-expression module containing genes associated with the metabolism
and splicing of mRNA (e.g., Cpsf6, Sfpq, Sfrs18). The effects of aging were, to a considerable degree,
similar among groups of co-expressed genes. Age-related gene expression patterns characteristic
of most mouse tissues were identified, including up regulation of granulin (Grn) and secreted
phosphoprotein 1 (Spp1). The transcriptional association between CR and aging varied at different
levels of analysis. With respect to gene subsets associated with certain biological processes (e.g.,
immunity and inflammation), CR opposed age-associated expression patterns. However, among all
genes, global transcriptional effects of CR were only weakly related to those of aging.
Conclusion: The study of aging, and of interventions thought to combat aging, has much to gain
from data-driven and unbiased genomic investigations. Expression patterns identified in this analysis
characterize a generalized response of mammalian cells to CR and/or aging. These patterns may be
of importance in determining effects of CR on overall lifespan, or as factors that underlie age-
related disease. The association between CR and aging warrants further study, but most evidence
indicates that CR does not induce a genome-wide "reversal" of age-associated gene expression
patterns.
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Background
The consumption of a low-calorie, but nutritionally suffi-
cient, diet has been found to improve indices of disease
risk in humans, and has been studied as an intervention
that increases lifespan in mice of most genetic back-
grounds. These effects of calorie restriction (CR) are
hypothesized to reflect not only prevention of particular
age-related diseases, but an actual interference with the
process of aging [1-3]. The physiological effects of CR
have therefore been of great interest from the standpoint
of human health [4], and much effort has been devoted to
development of drug compounds that "mimic" beneficial
aspects of low-calorie diets, without requiring a reduction
in overall caloric intake [5]. Despite decades of work
examining rodent responses to CR, however, the key bio-
chemical pathways underlying positive effects of this diet
on aging and lifespan remain to be elucidated [6]. The
most well-studied genes and pathways have emerged from
work in lower invertebrates, including the insulin/insulin-
like growth factor 1 system, the mammalian target of
rapamycin (mTOR), forkhead transcription factors, and
the sirtuin family of histone deacetylase genes [7]. Estab-
lishing the relative importance of these and other path-
ways in the mammalian CR effect provides avenues for
development of CR mimetic compounds, but also
advances a mechanistic understanding that should shed
light on unanswered questions. For instance, it is unclear
whether beneficial effects of CR arise from restriction of
specific nutrients (e.g., fat, methionine) [1], and for
unknown reasons, effects of CR on lifespan differ among
genotypes [8,9]. These issues may be addressed, in part, by
identifying pathways perturbed by CR and understanding
their functional contribution to increased lifespan.
Gene expression analyses using DNA microarrays cannot
reveal whether genes are causally involved in effects of CR
on lifespan, but are nonetheless powerful tools for identi-
fying new, and possibly unexpected, pathways that war-
rant further experimental investigation [10,11]. In mice,
previous studies have found that CR brings about large
shifts in gene expression, including tissue-specific
responses to CR, as well as a generalized or common CR
response that is shared among tissues [12,13]. Both tissue-
specific and common responses to CR are of potential
importance, but common responses to CR across multiple
tissue types provide especially attractive targets for further
study. Swindell (2008) [12] analyzed transcriptional
responses to CR across 10 tissue types in the laboratory
mouse, and found that common responses to CR include
activation of tumor suppressor genes, as well as anti-oxi-
dant and anti-inflammatory pathways. For instance, CR
was found to increase expression of metallothionein-
encoding genes (Mt1 and Mt2) in several tissues, includ-
ing liver, heart, muscle, hypothalamus, colon and lung.
Additionally, in multiple tissues, CR increased expression
of Nfkbia, an inhibitor of NF-kB, suggesting a potential
anti-inflammatory mechanism of CR diets [13]. More
recently, microarrays have been used to evaluate effects of
CR in previously unexamined tissues, including thymus,
gonads, mammary gland, spinal cord, cerebellum and
striatum [14-16]. These data allow common responses to
CR be refined, should lend greater confidence to lists of
CR-regulated genes and pathways, and provide an oppor-
tunity for applying improved statistical methods. For
instance, previous investigations have focused on how CR
affects individual genes, but this may reveal only part of
the story. A more comprehensive and informative
approach is to identify regions within the genome-wide
transcriptional network that are activated or inhibited by
CR [13].
Historically, the effects of CR have been viewed as being
associated with the aging process [1-3]. This standpoint
argues that effects of CR extend beyond any one disease
process (e.g., tumorigenesis), but that CR has multiplex
effects on a range of physiological systems, ultimately
amounting to an inhibitory effect on the progression of
aging. The association between CR and aging, however,
remains poorly understood, largely because the aging
process itself remains poorly defined [17]. While an
uncontroversial definition of aging may not be developed
anytime soon, it should be possible to add rigor to the
concept by generating quantitative models of aging that
are operationally useful. In this regard, whole-genome
microarray datasets would seem especially valuable [18],
and can be used to generate models that test, quantita-
tively, the assertion that CR acts to oppose the progression
of aging [11]. Conclusions generated from previous inves-
tigations conflict regarding the association between the
effects of CR and aging. On the one hand, an early inves-
tigation revealed that age-associated expression patterns
in muscle were "either completely or partially prevented
by caloric restriction" [19], and this conclusion was sup-
ported in subsequent studies [14,20,21]. Other investiga-
tions, however, have yielded different conclusions. For
instance, effects of CR were entirely unrelated to those of
aging in muscle tissue from Rhesus monkeys [22], and in
one aptly designed experiment examining mouse cardiac
tissue, only 79 of 1075 age-responsive genes (7.3%) were
significantly altered by CR [23]. Clearly, experimental
design and statistical methodology are two important
considerations for evaluating this diverse set of results.
Many studies, for instance, have not evaluated whether
the observed overlap between CR and aging effects is
larger than expected by chance alone. This statistical eval-
uation would not be straight-forward in many cases, since
experiments involved a shared control treatment that was
used to evaluate the effects of both aging and CR (e.g., a
young control treatment, an old control treatment, and an
old CR treatment). Given this design, the effect of CR isBMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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not estimated independently of the effect of aging, and
some correspondence between CR and aging effects
would be expected by chance [12].
The present study integrates results from a large number
of microarray experiments that have evaluated the effects
of CR or aging in the laboratory mouse. Collectively,
experiments analyzed in this report have evaluated the
effects of CR in 17 mouse tissue types, and the effects of
aging in 22 mouse tissue types. For many tissues, effects of
CR and/or aging have been evaluated in multiple studies,
and results from separate studies of the same tissue are
combined within a meta-analytic framework. The overall
approach was shaped by three main objectives. First, it
was of interest to identify robust expression patterns asso-
ciated with CR and aging, particularly common responses
occurring within multiple mouse tissues. Secondly, to
move beyond single-gene-centric analyses and to take full
advantage of the discernable co-expression relationships
among genes, regions of the transcriptional network acti-
vated or inhibited by CR or aging were identified (i.e.,
gene co-expression modules). Lastly, based on this cross-
study comparison of multiple datasets, it was of interest to
statistically evaluate whether CR acted to oppose age-asso-
ciated gene expression patterns. The overlap between the
effects of CR and aging was therefore evaluated using sev-
eral different methods, including overlap between differ-
ential expression signatures [24] and similarity between
ordered gene lists [25].
Results
Genes regulated by caloric restriction in the laboratory 
mouse
The CR dataset is a compilation of 40 experiments that,
taken together, have evaluated the effects of CR in 17 tis-
sue types (Table 1). For most tissues, data from just 1-3
experiments was available, but for well-studied tissues
(liver, muscle and heart), data was available from as many
as 10 separate experiments (Table 1). Additional File 1
provides detailed information regarding all experiments
incorporated into the analysis, including mouse strains
used in each study, sample sizes, array platforms, and
whether experimental results from a given study were val-
idated using RT-PCR. Differential expression results from
independent studies were combined using Fisher's p-
value combination method (see Methods). The symbol Pu
is used throughout to denote a p-value generated from a
one-sided hypothesis test for up regulation by CR (or
aging), while Pd denotes a p-value generated from a one-
sided hypothesis test for down regulation by CR (or
aging). The customary P (without subscript) represents a
two-sided p-value, generated by testing whether CR or
aging altered gene expression in either direction (up or
down). Unless otherwise indicated, p-values cited in the
text have been adjusted to account for multiple testing of
hypotheses among the 21,327 genes evaluated in the
analysis.
There was considerable heterogeneity among tissues in
terms of the number of genes for which information was
available, and with respect to the percentage of genes sig-
nificantly influenced by CR. For heart, liver, cochlea, mus-
cle, cortex, hypothalamus and colon, effects of CR had
been evaluated, in one or more experiments, for nearly all
21,327 genes included in the analysis (Figure 1A). For
other tissues, however, no data had been collected for
most known genes and information was available for less
than 4,000 genes (e.g., kidney) (Figure 1A). Based upon a
nominal type I error rate of 0.05, it was expected that at
least 5% of genes in any one tissue would be significantly
altered by CR. This was the case for 15 of 17 tissues, in
which CR altered more than 5% of the examined genes,
with as many as 54% of genes altered in the case of heart
(Figure 1A). For cerebellum and striatum, however, CR
significantly altered only 2 - 3% of the examined genes,
which is a smaller number of significant effects than
expected on the basis of chance (Figure 1A). The effects of
CR were characterized by constructing differential expres-
sion signatures associated with each tissue [24], and the
overlap among signatures was examined. Differential
expression signatures associated with CR in different tis-
sues usually overlapped by less than 40%, but this overlap
was often statistically significant (Figure 1B). A total of
136 pair-wise comparisons were made among 17 signa-
tures, and in 54 of these cases (39.7%), the overlap was
stronger than expected based on chance alone (P < 0.05).
There was strong similarity between some segments of the
central nervous system, such as spinal cord and cerebel-
lum, as well as hypothalamus and hippocampus, but
there was no overall tendency for signatures associated
with the central nervous system to cluster together (Figure
1C). For instance, effects of CR in the striatum were not
significantly similar to those in the cerebellum, spinal
cord, hippocampus, cortex and hypothalamus (Figure
1B).
For liver, heart and muscle, effects of CR had been evalu-
ated in more than four experiments, so detailed tissue-
specific analyses were carried out (see Additional Files 2,
3 and 4). A surprising outcome of these analyses was that,
although numerous genes emerged as significant in at
least one experiment for each tissue, relatively few genes
exhibited a consistent expression response to CR in multi-
ple experiments. In liver, for instance, after collecting
results across 10 experiments, only 10-15 genes were
found to respond to CR in a consistent fashion (Addi-
tional File 2). These consistent responses provide liver-
specific markers of CR response, and include up regula-
tion of Lpin1  and  Lpin2  (phosphatidate phosphatases
involved in fat metabolism), which were both increasedBMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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Table 1: Mouse tissue and cell types.
Tissue Symbol No. Experiments (CR) No. Experiments (Aging)
Liver lvr 10 8
Heart hrt 7 13
Muscle msl 4 4
White Adipose Tissue wat 3 -
Hippocampus hip 2 4
Cortex ctx 2 4
Hypothalamus hyp 2 -
Cerebellum cbm 1 7
Kidney kid 1 4
Lung lng 1 3
Thymus thm 1 2
Spinal Cord spc 1 1
Striatum str 1 1
Cochlea coc 1 1
Gonads gon 1 1
Mammary Gland mmy 1 -
Colon cln 1 -
Eye eye - 3
Whole Brain wbr - 3
Spleen spl - 2
Aorta art - 1
Gametes gam - 1
Myoblast Progenitor Cells myo - 1
Hematopoetic Stem Cells hsc - 1
Bone Marrow bmw - 1
Adrenals adr - 1
The table lists the tissue and cell types for which array data was available and incorporated into the analysis. Each tissue or cell type is referenced by 
a three-letter symbol listed in the second columns. The final two columns list, for each tissue or cell type, the number of independent array 
experiments that have investigated response to CR or aging. Additional File 1 provides details regarding each experiment incorporated into the 
analysis (e.g., % CR, duration of CR, ages examined, genetic background, type of array utilized).BMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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in each of 6 experiments for which data was available (Pu
< 4.12 × 10-8; P < 7.56 × 10-8). A second interesting aspect
of the response to CR in liver was that several expression
responses paralleled those resulting from growth hor-
mone/insulin-like growth factor 1 (GH/IGF-1) mutations
known to increase mouse lifespan [24]. For instance, in
liver, CR decreased expression of leukemia inhibitor fac-
tor receptor (Lifr) (Pd = 5.19 × 10-4; P = 9.39 × 10-4), insu-
lin-like growth factor acid labile subunit (Igfals) (Pd = 2.48
× 10-4; P = 4.20 × 10-4), kidney expressed gene 1 (Keg1) (Pd
= 8.64 × 10-5; P = 2.25 × 10-4), and the cytochrome P450
gene Cyp2f2 (Pd = 2.47 × 10-5; P = 8.61 × 10-5). Addition-
ally, CR increased expression of isocitrate dehydrogenase
2 (Idh2) (Pu = 2.06 × 10-5; P = 9.74 × 10-5), insulin-like
growth factor binding protein 1 (Igfbp1) (Pu = 1.09 × 10-3;
P = 6.90 × 10-3) and, very consistently, elevated expression
of flavin-containing monooxygenase 3 (Fmo3) (Pu = 2.81
× 10-8; P = 7.56 × 10-8) (see Additional File 2). Each of
these expression responses was previously identified in
association with multiple long-lived dwarf mutants,
which have reduced levels of GH and/or IGF-1 in circula-
tion [24].
Common responses to CR in multiple tissues included
genes identified previously [12], but also new genes not
uncovered in prior analyses. Given the large number of
experiments considered, the analysis provided substantial
statistical power, and overall, 29.7% of genes (6330/
21327) were significantly up regulated by CR across tis-
sues (Pu < 0.05), while 27.6% of genes (5884/21327)
were down regulated by CR across tissues (Pd < 0.05).
Given this large number of significant results, a more dis-
cerning criterion was to stratify genes according to the
number of tissues in which a gene was significantly up or
down regulated by CR. For instance, less than 1% of genes
(118/21327) were up regulated by CR with respect to 8 or
more tissue types, or down regulated by CR with respect
to 8 or more tissues (61/21327).
Figure 2 shows differential expression patterns associated
with genes for which expression was most responsive to
CR, in the same direction, across multiple tissue types.
Genes shown in Figure 2A were up regulated significantly
across all tissues (Pu < 8.15 × 10-7; P < 3.38 × 10-8), and
were each up regulated by CR significantly with respect to
9 or more individual tissues. Likewise, genes shown in Fig-
ure 2B were down regulated significantly across all tissues
(Pd < 4.93 × 10-5; P < 3.06 × 10-6), and were each down reg-
ulated by CR significantly with respect to 8 or more indi-
vidual tissues. Aside from p-values generated using
Fisher's method, the significance of genes shown in Fig-
ures 2A and 2B was confirmed by a second method, in
which simulation was used to generate null distributions
for a test statistic equal to the number of significant results
across all tissue types (assuming random association of
differential expression patterns among tissues) (P < 0.001
for each gene).
The most widespread effect of CR was up regulation of
serum/glucocorticoid regulated kinase 1 (Sgk1) in 11 tis-
sues, including colon, cochlea, kidney, lung, heart, liver
and white adipose tissue, as well as four regions of the
central nervous system (spinal cord, cortex, hippocampus
Differential expression patterns associated with caloric  restriction Figure 1
Differential expression patterns associated with 
caloric restriction. Differential expression signatures asso-
ciated with CR in each tissue were generated based upon 
integration of results from one or several datasets (see Table 
1). (A) The total height of each bar indicates the number of 
genes for which the effects of CR had been evaluated in at 
least one experiment (maximum of 21,327 genes). Colored 
sub-bars indicate the number of genes significantly up regu-
lated (red) or down regulated (green) by CR within each tis-
sue type (given a comparison-wise type I error rate of 0.05). 
Asterisk symbols (✴) indicate tissues for which a larger 
number of significant genes were identified than expected by 
chance. (B) The grid provides information on the pair-wise 
overlap between differential expression signatures associated 
with each tissue. The above-diagonal region is color-coded 
to reflect the distance between differential expression signa-
tures (d). The value of d ranges from 0 to 1, where low val-
ues of d indicate that, between two signatures being 
compared, there exists an over-abundance of genes signifi-
cantly regulated by CR in the same direction (see Methods). 
The region below the diagonal is coded in binary fashion, 
with dark squares indicating significant overlap between two 
differential expression signatures (P < 0.05) (see Methods). 
(C) An average linkage hierarchical cluster analysis was 
applied to differential expression signatures, where distance 
between signatures was based upon the measure d that is 
color-coded in the upper-diagonal region of the grid from 
part (B).
h
r
t
l
v
r
c
o
c
m
s
l
c
t
x
h
y
p
c
l
n
h
i
p
m
m
y
w
a
t
l
n
g
s
p
c
t
h
m
c
b
m
s
t
r
g
o
n
k
i
d
0
5
0
0
0
1
0
0
0
0
1
5
0
0
0
2
0
0
0
0
N
u
m
b
e
r
 
o
f
 
G
e
n
e
s No CR Effect
Decrease with CR
Increase with CR
(A)
gon
cbm
spc
coc
thm
str
kid
cln
lng
wat
mmy
hrt
lvr
hip
hyp
ctx
msl
m
s
l
c
t
x
h
y
p
h
i
p
l
v
r
h
r
t
m
m
y
w
a
t
l
n
g
c
l
n
k
i
d
s
t
r
t
h
m
c
o
c
s
p
c
c
b
m
g
o
n (B)
Distance(d)
< 0.05
0.05−0.10
0.10−0.15
0.15−0.20
0.20−0.30
0.30−0.40
0.40−0.50
0.50−0.60
> 0.60
gon
cbm
spc
coc
thm
str
kid
cln
lng
wat
mmy
hrt
lvr
hip
hyp
ctx
msl
0.4 0.2 0
Distance(d)
(C)BMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
Page 6 of 28
(page number not for citation purposes)
Common gene expression responses to CR in the laboratory mouse Figure 2
Common gene expression responses to CR in the laboratory mouse. Common gene expression responses to CR are 
ranked according to the number of tissue types in which genes were (A) significantly up regulated by CR or (B) significantly 
down regulated by CR. Additional File 5 provides a more comprehensive list of genes significantly regulated by CR across tis-
sues, with genes ranked by p-values generated from Fisher's method. Genes shown in part (C) were not identified as common 
responses to CR, but have previously been associated with the mammalian CR response. Symbols shown within the grid reflect 
results of differential expression analyses for individual genes and tissues, given a comparison-wise type I error rate of 0.05 (i.e., 
no p-value adjustment for multiple testing of hypotheses). Filled circles indicate that a gene was significantly up regulated by CR 
(red circle) (Pu < 0.05) or significantly down regulated by CR (green circle) (Pd < 0.05) within a given tissue. The dash symbol is 
used to indicate cases in which the effects of CR are non-significant, although colored dash symbols indicate that expression is 
marginally increased by CR (red dash) (0.05 < Pu < 0.10), or marginally decreased by CR (green dash) (0.05 < Pd < 0.10). The 
asterisk symbol (✴) is used to designate instances where CR has significant effects, but there exists conflict among datasets. 
This may arise if at least two experiments exist, with at least one showing significant up regulation by CR (Pu < 0.05), and at 
least one demonstrating significant down regulation by CR (Pd < 0.05). Additionally, the asterisk is used when p-values, gener-
ated by combining results across experiments (Fisher's method), yield conflicting results in terms of whether a gene is up or 
down regulated (i.e., both Pu < 0.05 and Pd < 0.05). Asterisk symbols are colored red if there is stronger evidence that the gene 
is up regulated by CR (i.e., Pu < 0.05 and Pu < Pd), and are colored green if there is stronger evidence that the gene is down reg-
ulated by CR (i.e., Pd < 0.05 and Pd < Pu). The multiplication symbol (×) is used for cases in which no information was available 
regarding the effects of CR within a given tissue.
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and hypothalamus) (Figure 2A) (Pu = 1.04 × 10-10; P =
1.31 × 10-10). Additionally, and consistent with previous
analyses [12], CR increased expression of metallothionein
2 (Mt2) in 10 tissues (Pu= 4.58 × 10-10; P = 1.74 × 10-13),
and down regulated the collagen-specific molecular chap-
erone Serpinh1 in 8 tissues, including regions within the
central nervous system (hypothalamus, hippocampus and
striatum) (Pd = 7.65 × 10-9; P = 1.98 × 10-10) (Figure 2B).
A previous study has confirmed, by RT-PCR, that Serpinh1
is down regulated by CR in heart, liver and hypothalamus
[26]. In Figure 2A and 2B, genes are ranked according to
the total number of tissues in which CR increased or
decreased expression significantly. Additional File 5 pro-
vides a comprehensive list using an alternative ranking
scheme (based upon the Fisher p-value). This alternative
approach highlighted some strong CR effects not shown
in Figure 2, including increased expression of Tsc22d3,
Zbtb16, BC055107, Sult1a1, Per1, Timp3, S3-12, Pnpla2,
Ppargc1a and Cp, as well as decreased expression of Ifitm3,
Lasp1, Tia1, 5830428H23Rik, Hsp90b1, Hist1h2bc, Cxcl12,
Col6a2 and Dock4 (see Additional File 5). Additional File
5 also provides analyses of gene ontology terms, KEGG
pathways, associated microRNAs, and chromosomal loca-
tions. Overall, genes most strongly increased by CR across
tissues were associated with fatty acid metabolism, the cit-
rate cycle, PPAR signaling, oxidative phophorylation,
amino acid degradation and metabolism, circadian
rhythm, renal cell carcinoma, fatty acid elongation in
mitochondria and the insulin signaling pathway (P <
0.01; over-represented KEGG pathways) (Additional File
5). Genes commonly down regulated by CR were associ-
ated with focal adhesion, antigen processing and presen-
tation, ECM-receptor interaction, DNA replication, MAPK
signaling, cell communication, VEGF signaling and natu-
ral killer cell mediated cytotoxicity (P < 0.01; over-repre-
sented KEGG pathways) (Additional File 5).
Genes listed in Figures 2A and 2B have not been well-stud-
ied in relation to the effect of CR in mouse. For instance,
a series of PubMed searches was conducted (in September
2009), where each gene name was searched in conjunc-
tion with the phrase "caloric restriction". This search
yielded one record associated with Sgk1  and  Hspb1,
respectively, but no PubMed records were retrieved for
any other gene shown in Figures 2A and 2B. Figure 2C
shows differential expression patterns of genes receiving
greater research attention, such as sirtuin 1 (Sirt1), for
which the above-mentioned search procedure retrieved
106 PubMed records. Sirt1 expression was significantly
increased by CR in the cochlea, and significantly
decreased in muscle and white adipose tissue, but overall,
was not significantly regulated by CR across tissues (Pu =
0.723; Pd = 0.133; P = 0.068) (Figure 1C). Of the 7 sirtuin
gene family members, CR had the strongest effect on the
Table 2: CR-regulated co-expression modules
Modules M (P-Value) Minimal |r|
{Fmo2, 1200016E24Rik} 10.7 (0.062) 0.703
{Hist2h3c1, Hist2h3c2} 10.5 (0.136) 0.817
{Per1, Per2} 10.1 (0.393) 0.597
{Hist2h3c1, Hist2h3c2, Hist1h2bc} 10.2 (0.004) 0.700
{Per1, Per2, Zbtb16} 10.0 (0.008) 0.596
{Epm2aip1, Casc4, 2810455D13Rik} 9.73 (0.033) 0.568
{Hist2h3c1, Hist2h3c2, Hist1h2bc, Hist2h2aa1, Hist1h1c} 9.79 (< 0.001) 0.595
{Per1, Per2, Zbtb16, Mm.34106, 1439537_at} 9.29 (< 0.001) 0.564
{Alkbh8, Zfp148, Rc3h2, Zdhhc21, Taok1} 8.91 (0.006) 0.494
The table lists the most significant CR-regulated co-expression modules containing 2, 3, or 5 genes. The M statistic is an indicator of responsiveness 
to CR, with larger values suggesting stronger effects of CR on the expression of genes contained in a given module (see Methods). P-values 
associated with M statistics were generated by simulation, and reflect the likelihood of obtaining an equal or larger M value by randomly selecting 
genes to form a module of the same size (see Methods). The final column provides an indication of the degree to which module members are co-
expressed with one another. This value is an element of the [0, 1] interval, and is obtained by calculating all possible pair-wise co-expression 
relationships among members of the module (all possible values of r), and identifying the weakest co-expression relationship between any two 
module members (i.e., the minimal value of |r|). Smaller minimal |r| values indicate more "diffuse" co-expression modules with weaker co-
expression relationships, and larger minimal |r| values indicate "tighter" co-expression modules with stronger co-expression relationships. 
Additional File 6 provides a more detailed description of these and other co-expression modules that emerged as significantly associated with CR.BMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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expression of sirtuin 5 (Sirt5), which was significantly
increased by CR in colon, cochlea and cortex, and signifi-
cantly decreased by CR in heart, liver and muscle (Pu =
0.033; Pd = 0.049; P = 3.81 × 10-5) (Figure 2C). Interest-
ingly, the Igf1 transcript was significantly regulated by CR,
but there was heterogeneity among tissues in the direction
of this effect. In colon, lung, muscle, white adipose tissue
and hypothalamus, Igf1 expression was decreased by CR,
but the opposite trend was found in cochlea, heart, cortex
and mammary gland (Figure 2C). Overall, across all tis-
sues, there was significant evidence for decreased expres-
sion of Igf1 by CR (Pu = 0.070; Pd = 1.90 × 10-4; P = 1.71 ×
10-8).
Gene expression modules regulated by caloric restriction
The above analyses consider CR-responsiveness of indi-
vidual genes, taken one at a time, but do not consider the
organization among genes based upon their patterns of
co-expression. For each gene, therefore, a "nearest-neigh-
bor" co-expression module was generated by finding
"neighbor" genes with correlated patterns of expression,
based upon a reference set of 3,700 Affymetrix oligonucle-
otide arrays (see Methods). Nearest-neighbor modules of
varying sizes were constructed for each gene included in
the analysis (2, 3, 5, 10, 20 and 40 genes per module).
Each module was then scored based upon an M statistic
designed to quantify responsiveness of modules to CR,
and the significance of observed M values was evaluated
by simulations in which modules of a given size were
formed at random (see Methods). A total of 3, 5, 22, 39
and 28 significant CR-responsive modules with 3, 5, 10,
20 and 40 genes, respectively, were identified. Table 2 lists
the most significant CR-regulated co-expression modules
of smaller size, and all significant modules of each size are
shown in Additional File 6.
The approach identified 2-gene co-expression modules
that were responsive to CR, some of which included func-
tionally related gene pairs, such as {Hist2h3c1, Hist2h3c2}
and {Per1, Per2} (M > 10.1) (Additional File 6). Of the 2-
gene modules, only {Fmo2, 1200016E24Rik} was margin-
ally significant (M = 10.7; P = 0.062), although others
were often components of larger modules that were statis-
tically significant (Additional File 6). For instance, signif-
icant 3-gene modules included {Hist2h3c1,  Hist2h3c2,
Hist1h2bc} and {Per1, Per2, Zbtb16} (M > 10.0; P < 0.008;
Additional File 6). The composition of CR-responsive
modules often revealed unexpected associations between
genes. For instance, the most significant 10-gene module
included six genes that encode histone cluster subunits,
along with genes encoding an RNA binding protein
(Cstf2) and a peroxisomal beta-oxidation system enzyme
(Acox1) (M = 8.55; P < 0.001; see Additional File 6). The
second-most significant 10-gene module included three
period homologue genes (Per1, Per2 and Per3), a TSC22
domain family gene with anti-inflammatory effects
(Tsc22d3) [27], and a gene known to negatively regulate
tumorigenesis (Zbtb16) [28] (M = 8.40; P < 0.001; see
Additional File 6). It was often the case that genes belong-
ing to the same module exhibited similar responses to CR
within the same tissues (Additional File 6).
Gene expression module regulated by CR Figure 3
Gene expression module regulated by CR. The figure 
shows a 40-gene co-expression module that is regulated by 
CR across multiple tissue types. Symbols shown within the 
grid reflect results of differential expression analyses for indi-
vidual genes and tissues, given a comparison-wise type I 
error rate of 0.05 (i.e., no p-value adjustment for multiple 
testing of hypotheses). These symbols have the same inter-
pretation as those shown in Figure 2. The columns of the 
grid, corresponding to individual tissue types, have been 
ordered from those for which module genes are most 
strongly up regulated by CR, to those for which module 
genes are most strongly down regulated by CR. The dendro-
gram (left) reflects the co-expression patterns among the 40 
genes belonging to this module, which are based upon the 
expression of genes across a set of 3,700 Affymetrix 430 2.0 
oligonucleotide arrays (see Methods). The dendrogram was 
generated by average linkage hierarchical cluster analysis, 
with distance between genes based upon the absolute value 
of Pearson's correlation coefficient (i.e., distance = 1 - |r|). 
Other CR-regulated co-expression modules were identified 
in the analysis, and further detail on the most significant of 
these is provided in Additional File 6.
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The most CR-responsive 40-gene module included genes
associated with mRNA processing and transcriptional reg-
ulation (M = 7.61; P < 0.001; see Figure 3). The "center"
of this module was the zinc finger protein 871 (Zfp781/
9030612M13Rik), with the remaining 39 genes being
nearest neighbors of Zfp781. Genes belonging to this
module were highly responsive to CR, but the direction of
response differed among tissue types (Figure 3). In coch-
lea, hypothalamus and colon, nearly all member genes
were significantly up regulated by CR. However, in hip-
pocampus, mammary gland and liver, genes in this mod-
ule were usually down regulated by CR (Figure 3). Gene
ontology analysis revealed that member genes were
involved in transcriptional processes, particularly splic-
ing, metabolism, processing and biosynthesis of RNA (P <
0.05). Along these lines, a disproportionately large
number of module genes were associated with the
nucleus, chromosome and spliceosome (P < 0.05).
Genes regulated by aging in the laboratory mouse
The effects of aging on gene expression had been evalu-
ated in 67 experiments and a total of 22 tissue types (Table
1). On average, aging altered 22.9% of genes, with the
strongest effects found in the cortex (44.0% of genes dif-
ferentially expressed) (P < 0.05). Among those tissues
with the strongest age effects (cortex, liver, cerebellum,
heart, aorta), more genes increased with age than
decreased with age (Figure 4). The weakest effects of aging
were associated with cochlea and striatum, in which aging
altered only 2-4% of genes, which is fewer than expected
by chance at the nominal type I error rate of 0.05 (Figure
4A). For some tissues, aging had a larger impact on gene
expression than observed in prior studies. In cerebellum,
for example, at a type I error rate of 0.001, aging altered
the expression of 2168 of 21327 genes (10.2%). This per-
centage is considerably higher than that observed in the
AGEMAP project [29], in which aging altered the expres-
sion of only 17 of 8932 genes (0.19%) (P < 0.001). This
apparent difference in effect size may reflect increased sta-
tistical power associated with a meta-analytic approach,
or differences in the relative amount of noise influencing
expression measurements generated using different array
platforms. Differential expression signatures were con-
structed to characterize the effects of aging in each tissue,
and comparisons of these signatures suggested that, rela-
tive to CR, effects of aging were more correspondent
among different tissue types. For instance, among 231
pairwise comparisons between signatures, significant
overlap was found in 158 cases (68.4% of comparisons)
(Figure 4B), and a cluster analysis indicated that 12 of the
22 tissues formed a single group with similar patterns of
differential expression (Figure 4C).
A side-by-side comparison of results from multiple exper-
iments examining the same tissue highlighted robust tis-
sue-specific markers of aging (Additional Files 7, 8 and 9).
For instance, in each of seven experiments evaluating the
effects of aging in liver, expression of immunoglobulin
joining chain (Igj) increased (Pu = 7.63 × 10-9; P = 1.04 ×
10-8), while expression of kidney expressed gene 1 (Keg1)
decreased (Pd = 3.14 × 10-7; P = 3.73 × 10-7) (Additional
Differential expression patterns associated with aging Figure 4
Differential expression patterns associated with 
aging. Differential expression signatures associated with 
aging in each tissue were generated based upon integration 
of results from one or several datasets (see Table 1). (A) The 
total height of each bar indicates the number of genes for 
which the effects of aging had been evaluated in at least one 
experiment (maximum of 21,327 genes). Colored sub-bars 
indicate the number of genes significantly up regulated (red) 
or down regulated (green) by aging within each tissue type 
(given a comparison-wise type I error rate of 0.05). Asterisk 
symbols (✴) indicate tissues for which a larger number of sig-
nificant genes were identified than expected by chance. (B) 
The grid provides information on the pair-wise overlap 
between differential expression signatures associated with 
each tissue. The above-diagonal region is color-coded to 
reflect the distance between differential expression signa-
tures (d). The value of d ranges from 0 to 1, where low val-
ues of d indicate that, between two signatures being 
compared, there exists an over-abundance of genes signifi-
cantly regulated by aging in the same direction (see Meth-
ods). The region below the diagonal is coded in binary 
fashion, with dark squares indicating significant overlap 
between two differential expression signatures (P < 0.05) 
(see Methods). (C) An average linkage hierarchical cluster 
analysis was applied to differential expression signatures, 
where distance between signatures was based upon the 
measure d that is color-coded in the upper-diagonal region of 
the grid from part (B).
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File 7). The effects of aging in cardiac tissue had been
examined in an especially large number of experiments
(Additional File 8). Comparison of these experiments
indicated that aging increased cardiac expression of phe-
nylalanine hydroxylase (Pah) in all 12 experiments for
which data was available (Pu = 5.08 × 10-16; P = 4.87 × 10-
15). Likewise, aging increased cardiac expression of com-
plement component 4B (C4b) in 11 experiments for
which data was available (Pu= 5.08 × 10-16; P = 4.87 × 10-
15). These results confirm and extend observations from a
recent expression profiling study of age-associated gene
expression patterns in cardiac tissue from multiple mouse
strains, which identified both Pah  and  C4b  as robust
biomarkers of cardiac aging, and confirmed these age-
related expression patterns using RT-PCR [11]. In muscle,
an age-related increase of heat shock protein 90
(Hsp90aa1) expression was observed in four separate
experiments (Pu = 0.011; P = 0.019), as well as an age-
associated decrease of Col1a2 expression (Pd = 8.26 × 10-3;
P = 4.73 × 10-3).
Genes with age-related expression patterns in multiple tis-
sue types were identified using Fisher's method. This
revealed that 7709 genes (36.1%) were significantly up
regulated with age across all tissues (Pu < 0.05), while
7872 genes (36.9%) were significantly down regulated
with age across all tissues (Pd < 0.05). There were strong
functional differences between genes that increased with
age in multiple tissues and genes that decreased with age
in multiple tissues (Additional File 10). Genes up regu-
lated with aging were frequently associated with immune
response, and over represented gene ontology terms
included antigen processing and presentation, lym-
phocyte mediated immunity, immunoglobulin mediated
immune response, humoral immune response, lysosome
organization/biogenesis, and regulation of adaptive
immune response (P < 0.05; Gene Ontology biological
process terms; Additional File 10). However, this was not
generally true of genes decreased with age. Genes down
regulated with aging in multiple tissues were more com-
monly associated with metabolic processes, chromosome
organization/biogenesis, cell division and cycle, mRNA
processing and splicing, and protein folding (P < 0.05)
(Additional File 10).
Figure 5A displays differential expression patterns of
genes significantly up regulated by age across all tissues
(Pu < 1.25 × 10-9; P = 7.38 × 10-11), with significant
increases in 13 or more tissue types. Likewise, Figure 5B
displays this information for genes significantly decreased
by aging across tissues (Pd < 1.47 × 10-9; P = 4.32 × 10-11),
with significant effects in at least 11 tissues. The signifi-
cance of all genes in Figures 5A and 5B was confirmed
based upon a simulation analysis that treated the total
number of significant results across all tissues as a test sta-
tistic (P < 0.001). Additional File 10 provides a more com-
prehensive list of genes with age-related expression in
multiple tissues, with genes ranked according to Fisher p-
values. Genes most strongly up regulated with age were
often immune-related, including major histocompatabil-
Common gene expression responses to aging in the labora- tory mouse Figure 5
Common gene expression responses to aging in the 
laboratory mouse. Common gene expression responses 
to aging are ranked according to the number of tissue types 
in which genes were (A) significantly up regulated with age or 
(B) significantly down regulated with age. Genes shown in 
part (C) were not identified as common responses to aging, 
but have previously been associated with aging in mammals. 
Symbols shown within the grid have the same interpretation 
as those in Figure 2 (with p-values based upon a comparison-
wise type I error rate of 0.05), except aging is the experi-
mental factor (rather than CR). Additional File 10 provides a 
more comprehensive list of genes significantly regulated by 
aging across tissues, with genes ranked by p-values generated 
from Fisher's method.
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ity complex (MHC) genes (H2-D1, H2-K1, H2-Q7, H2-L,
H2-Aa,  H2-T10,  H2-M3,  H2-T23), and several genes
encoding immunoglobulin chain components (e.g., Igk-
V1, Igh-6, Igj, Igh, Igl-V1) (Figure 5A; Additional File 10).
Expression of H2-D1, for instance, increased with age in
15 tissue types, including the central nervous system
(whole brain, cortex, cerebellum, hippocampus), and sev-
eral other major organ types (e.g., liver, heart, kidney) (Pu
= 1.25 × 10-16; P = 8.90 × 10-18) (Figure 5A). In both liver
and thymus, a strong age-related increase in the expres-
sion of such immune-associated genes has previously
been confirmed using RT-PCR [30,31]. Genes down regu-
lated with age in multiple tissues were more diverse, and
included heat shock proteins (Hspa8), along with genes
involved in mRNA processing (Sfrs7 and Syncrip) (Figure
5B).
The age-related expression patterns of identified genes
were more widespread than those of some genes previ-
ously associated mammalian aging and cellular senes-
cence (Figure 5C). Based on previous investigations [32-
34], for instance, it was expected that aging would increase
expression of Cyclin-dependent kinase inhibitor 2A
(Cdkn2a/p16INK4A) and Ets homologous factor (Ehf),
and that aging would decrease expression of senescence
marker protein 30 (Smp30/Rgn). For these genes, however,
significant effects of aging were observed only in a few tis-
sues, and often, the effect was inconsistent with prior
expectations. For instance, Cdkn2a/p16INK4A is a regula-
tor of the cell cycle, and it has been proposed that expres-
sion of Cdkn2a is a biomarker of aging in multiple mouse
tissues [32]. But there was little indication that Cdkn2a
expression increased with age in most tissues, and overall,
the effect of age on Cdkn2a expression was nonsignificant
Table 3: Age-regulated co-expression modules
Modules M (P-Value) Minimal |r|
{Nckap1l, Evi2a} 10.2 (0.101) 0.946
{Plek, Ncf1} 9.96 (0.208) 0.908
{Sfi1, 4933439C20Rik} 9.93 (0.235) 0.780
{Psmb8, Psmb9, H2-K1} 10.0 (< 0.001) 0.859
{Tyrobp, Mpeg1, Ctss} 9.87 (< 0.001) 0.863
{Sfi1, Pisd, 4933439C20Rik} 9.85 (< 0.001) 0.599
{Tyrobp, Mpeg1, Fcgr3, Fcer1g, Plek} 9.85 (< 0.001) 0.821
{Psmb8, Psmb9, H2-M3, H2-K1, Tap2} 9.29 (< 0.001) 0.813
{Evi2a, Ly86, Pkib, March1, Lair1} 9.16 (< 0.001) 0.713
The table lists the most significant age-regulated co-expression 
modules containing 2, 3, or 5 genes. Values in this table are 
interpreted in the same way as those listed in Table 2, except here 
the M statistic reflects responsiveness of a module to aging (rather 
than CR). Additional File 11 provides a more detailed description of 
these and other co-expression modules that emerged as significantly 
associated with aging.
Gene expression module regulated by aging Figure 6
Gene expression module regulated by aging. The fig-
ure shows a 40-gene co-expression module that is regulated 
by aging across multiple tissue types. Symbols shown within 
the grid reflect results of differential expression analyses for 
individual genes and tissues, given a comparison-wise type I 
error rate of 0.05 (i.e., no p-value adjustment for multiple 
testing of hypotheses). These symbols have the same inter-
pretation as those shown in Figure 2. The columns of the 
grid, corresponding to individual tissue types, have been 
ordered from those for which module genes are most 
strongly up regulated by age, to those for which module 
genes are most strongly down regulated by age. The dendro-
gram (left) reflects the co-expression patterns among the 40 
genes belonging to this module, which are based upon the 
expression of genes across a set of 3,700 Affymetrix 430 2.0 
oligonucleotide arrays (see Methods). The dendrogram was 
generated by average linkage hierarchical cluster analysis, 
with distance between genes based upon the absolute value 
of Pearson's correlation coefficient (i.e., distance = 1 - |r|). 
Other age-regulated co-expression modules were identified 
in the analysis, and further detail on the most of these is pro-
vided in Additional File 11.
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among all tissue types (Pu = 0.921; Pd = 0.094; P = 0.178).
The expression of Cdkn2a increased significantly only in
cardiac tissue with age, and in cortex, Cdkn2a expression
decreased with age (Figure 5C).
Gene expression modules regulated by aging
Nearest-neighbor co-expression modules ranging in size
from 2 to 40 genes were formed and the collective
response of each module to aging across tissues was eval-
uated. The results demonstrate strong modularity of age-
related expression patterns, with certain sets of co-
expressed genes exhibiting correspondent differential
expression patterns with age. A total of 5, 15, 43, 52 and
38 significant age-responsive modules with 3, 5, 10, 20
and 40 genes, respectively, were identified (Additional
File 11). The most significant 3-gene module included
two proteasome subunit genes (Psmb8 and Psmb9), along
with the MHC antigen H2-K1 (M = 10.0; P < 0.001; see
Table 3). The three genes contained in this module exhib-
ited highly correspondent patterns of differential expres-
sion, with decreased expression occurring in spleen with
age, and an age-related up regulation of expression across
13 tissues (Additional File 11). A similar pattern was
present with respect to other 3-gene co-expression mod-
ules, such as {Tyrobp,  Mpeg1,  Ctss} and {Sfi1,  Pisd,
4933439C20Rik}, and with significant co-expression
modules of larger size (Additional File 11). In each of
these cases, genes belonging to the same module exhib-
ited similar differential expression patterns in the same
tissues, indicating that patterns of co-expression had con-
siderable explanatory power in terms of age-related tran-
scriptional effects.
The most significant 40-gene module was centered
around cathepsin S (Ctss) (Figure 6). The rest of the mod-
ule consisted of the 39 nearest neighbors of Ctss, which
included genes encoding complement components
(C1qa, C1qb and C1qc) and antigens (Cd48, Cd52 and
Cd53). Strikingly, nearly every gene in this module exhib-
ited an age-related expression increase in liver, kidney,
cerebellum, cortex, eye, aorta, lung, heart, hippocampus
and whole brain (Figure 6). Among genes belonging to
the module, a gene ontology analysis revealed numerous
over-represented biological processes, including activa-
tion of immune response, positive regulation of B cell
mediated immunity, phagocytosis, inflammatory
response and neutrophil chemotaxis (P < 0.01). Half of
module genes were associated with membrane (20 and 40
genes; P < 0.001), particularly the plasma membrane (8 of
40 genes; P < 0.01). The second-most significant 40-gene
module (see Additional File 11) was not associated with
inflammation or immune response, but interestingly,
included genes with roles in mRNA processing, RNA
transport and RNA localization. Most of the genes in this
module were associated with the nucleus (24 of 40 genes)
and several were among the most age-responsive genes
identified in the analysis, such as Gspt1, Ints8, Syncrip and
Creb1 (Figure 5B). In contrast to the module shown in Fig-
ure 6, most member genes were predominantly decreased
with aging, particularly in aorta, gametes and cardiac tis-
sue (Additional File 11).
Relationship between caloric restriction and aging
CR is thought to inhibit the progression of aging and to
oppose age-related gene expression patterns. It was there-
fore expected that a negative association would exist
between transcriptional effects of CR and aging, and sev-
Relationship between caloric restriction and aging Figure 7
Relationship between caloric restriction and aging. 
The association between CR and aging was evaluated for 
genes most strongly increased CR across tissues (Figure 2A), 
genes most strongly decreased by CR (Figure 2B), genes 
most strongly increased by aging (Figure 5A), and genes most 
strongly decreased by aging (Figure 5B). The "CR effect" is 
positive for genes up regulated by CR across tissues and neg-
ative for genes down regulated by CR across tissues. Like-
wise, the "age effect" is positive for genes up regulated with 
age across tissues and negative for genes down regulated 
with age across tissues. The magnitude of the CR effect and 
age effect reflects the degree of statistical significance. In par-
ticular, the CR effect is equal to I * -log[min(Pu, Pd)], where Pu 
and Pd are p-values generated by one-sided hypothesis tests 
of up and down regulation by CR across tissues, while I is 
equal to 1 if Pu <Pd and is equal to -1 otherwise. Similarly, the 
age effect is equal to I * -log[min(Pu, Pd)], where Pu and Pd are 
p-values generated by one-sided hypothesis tests of up and 
down regulation by aging, while I is equal to 1 if Pu < Pd and is 
equal to -1 otherwise.
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eral approaches were taken to evaluate whether such an
association was present. First, genes most strongly regu-
lated by CR or aging across multiple tissue types were con-
sidered (see Figures 2 and 5). There was no general
tendency for genes increased by CR across tissues to be
decreased by aging, and likewise, genes decreased by CR
across tissues were not disproportionately increased by
aging (Figure 7). Individual genes can be identified that
either support or contradict the expected pattern. For
instance, CR decreased expression of Igh-6 and Marcks,
and this effect does indeed oppose increased expression of
these genes with age across tissues. On the other hand, CR
decreased expression of Col3a1, and this effect would
seem to mimic, rather than oppose, age-related decreases
in Col3a1 expression (Figure 7).
The association between CR and aging was next examined
at the global scale, among all genes, and also with respect
to each of the four most well-studied tissue types (liver,
heart, muscle and central nervous system) (Figure 8). In
liver, there was a slight, positive association between the
effects of CR and aging (r = 0.04) (Figure 8A). This associ-
ation was significant (P < 6.72 × 10-12), although given the
large number of genes involved in the comparison, this
Relationship between caloric restriction and aging in liver, heart, muscle and the central nervous system Figure 8
Relationship between caloric restriction and aging in liver, heart, muscle and the central nervous system. The 
association between CR and aging was evaluated for the (A) liver, (B) heart, (C) muscle and (D) central nervous system (hip-
pocampus + cortex). The CR effect is positive for genes up regulated by CR and negative for genes down regulated by CR (see 
Figure 7 legend). Likewise, the age effect is positive for genes up regulated with age and negative for genes down regulated with 
age (see Figure 7 legend). The abundance of genes in relation to the CR and age effect is reflected by the color intensity, with 
deep blue colors corresponding to regions with the largest number of genes. The dashed red line is based upon a least-squares 
regression fit that quantifies the overall relationship between the CR and aging effects. In each panel, the estimated Pearson 
correlation is shown in the upper-right, and the percentage values (green font) indicate the fraction of genes that belong to 
each quadrant. The effects of CR and aging were computed in each organ system based upon p-values generated by combining 
results from at least 3 independent experiments. In liver, CR and aging effects are based upon 9 and 7 experiments, respec-
tively. In heart, CR and aging effects are based upon 5 and 10 experiments, respectively. For muscle and central nervous sys-
tem, CR and aging effects are each based upon 3 -6 experiments. For each organ, distinct sets of data were used to estimate 
the CR and aging effects, such that CR and aging effects are a priori independent.
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significance test was not too informative. In the heart,
muscle and central nervous system, the expected negative
association between CR and aging did emerge, albeit
weakly, with the estimated correlation coefficient less
than or equal to -0.10 in each case. The strongest associa-
tion was found in heart (Figure 8B), in which age-related
expression patterns were weakly opposed by CR (r = -
0.096; P = 2.20 × 10-16). In muscle and central nervous
system (Figures 8C and 8D), the association between CR
and aging was again weak (r < -0.048), and non-signifi-
cant in the case of muscle (P = 0.054), despite the large
number of genes upon which the association was based.
With respect to central nervous system, a large fraction of
genes (56.6%) were both increased by CR and decreased
with age (i.e., within the lower-right quadrant of Figure
8D), although very few genes (8.9%) were decreased by
CR and increased with age (i.e., within the upper-left
quadrant of Figure 8D).
The global effects of CR and aging were then compared by
evaluating the association between differential expression
signatures. In this analysis, it was expected that genes sig-
nificantly increased by CR would tend to be decreased sig-
nificantly with age, and conversely, that genes
significantly decreased by CR would increase significantly
with age. Associations between differential expression
patterns were found (Figure 9), and were moderately
strong in liver (c2 = 295.8; P < 2.2 × 10-16), weaker in heart
(c2 = 64.22; P = 2.94 × 10-13), weakest in muscle (c2 =
6.56; P = 0.161), and strongest in the central nervous sys-
tem (c2 = 330; P < 2.2 × 10-16). The pattern of association,
however, varied among tissues, and was often not consist-
ent with the expectation. In liver and central nervous sys-
tem, CR did oppose age-related expression patterns, but
these trends were complicated by the fact that, in each tis-
sue type, there was a significant tendency for CR to actu-
ally reinforce the effects of aging, which is in complete
Relationship between caloric restriction and aging in liver, heart, muscle and the central nervous system. Association between  differential expression signatures Figure 9
Relationship between caloric restriction and aging in liver, heart, muscle and the central nervous system. 
Association between differential expression signatures. The association between CR and aging was evaluated for the 
(A) liver, (B) heart, (C) muscle and (D) central nervous system (hippocampus + cortex). For each tissue, a differential expres-
sion signature was constructed corresponding to the effects of CR, and another signature was constructed corresponding to 
the effects of aging. Both signatures were based upon 3 or more experiments (see Figure 8 legend). CR and aging signatures 
were cross-tabulated, to place component genes into 9 separate categories, depending upon whether genes were increased by 
CR and/or aging (+), decreased by CR and/or aging (-), or whether CR and/or aging had no significant effect on gene expression 
(o). For each category, bars represent the adjusted Pearson residual (see Methods) (94). The absolute value of this quantity 
reflects the degree to which gene counts differ from what is expected based upon a random association between the CR and 
aging differential expression signatures. Positive residuals indicate that more genes belong to that category than expected by 
chance, given a random association between the effects of CR and aging. Negative residuals indicate that fewer genes belong to 
that category than expected by chance, given a random association between the effects of CR and aging. The adjusted Pearson 
residuals follow a standard normal distribution, with residuals larger than 3 in absolute value suggestive of significant, non-ran-
dom associations between the effects of CR and aging [94]. The bars outlined in red indicate a significantly large or small resid-
ual (P < 0.05).
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contrast to the expectation stated above (Figures 9A and
9D). In muscle, the relationship between CR and age-
related differential expression patterns was effectively ran-
dom, with little or no evidence of any association (Figure
9C). The strongest evidence for the expected CR-aging
relationship was again found with respect to heart. In car-
diac tissue, there was a significant abundance of genes
increased by CR and decreased by age, as well as an abun-
dance of genes decreased by CR and increased by age (Fig-
ure 9B). These conclusions were reinforced by results from
an alternative analytical method, based upon correspond-
ence between ranked gene lists [25], which also showed
conflicting associations between CR and aging in liver,
muscle and central nervous system (Figures 10ACD), with
a stronger and more clear-cut relationship in heart (Figure
10B).
The above results suggest that, among all genes, the tran-
scriptional association between effects of CR and aging is
limited, with a stronger relationship in heart relative to
Relationship between caloric restriction and aging in liver, heart, muscle and the central nervous system. Association between  ordered gene lists Figure 10
Relationship between caloric restriction and aging in liver, heart, muscle and the central nervous system. 
Association between ordered gene lists. The association between the effects of CR and aging were evaluated in (A) liver, 
(B) heart, (C) muscle and (D) central nervous system (hippocampus + cortex). The association was evaluated following the 
approach of Lottaz et al. (2006) [25]. For each tissue type, four ordered lists of genes were generated (abbreviated as: CRu, 
CRD, AGEu, AGED). The CRu list contained the 2,500 genes most strongly up regulated by CR, ordered according to the signif-
icance of this effect (i.e., most-to-least significant). Likewise, the CRD list contained the 2,500 genes most strongly down regu-
lated by CR, ordered according to the significance of this effect (i.e., most-to-least significant). Similarly, the AGEU list contained 
the 2,500 genes most strongly up regulated with age, and the AGED list contained the 2,500 genes most strongly down regu-
lated with age (ordered from most-to-least significant). In each panel, blue lines indicate the degree of overlap between CR and 
AGE gene lists, with respect to gene ranks between 1 and 2,500. On the right side of each panel, solid blue lines represent the 
overlap between CRU and AGEU, while dotted blue lines represent the overlap between CRUand AGED. On the left side of 
each panel, solid blue lines represent the overlap between CRD and AGED, while dotted blue lines represent the overlap 
between CRD and AGEU. Red bands in each plot correspond to 95% confidence intervals for the degree of overlap expected by 
chance (based on the hypergeometric distribution) (25). Given an inverse association between CR and aging, it is expected that 
dotted blue lines would fall above the region shown in red, whereas the solid blue lines would fall within (or below) the region 
shown in red.
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other tissue types. One possibility is that the transcrip-
tional association between CR and aging is stronger
among genes associated with some biological processes,
and weaker among certain genes associated with other
processes. The CR-aging association was thus examined
with respect to gene ontology biological process terms
that were associated with genes increased or decreased by
aging across all mouse tissues (Figures 11 and 12). This
analysis revealed definite differences among gene catego-
rizations with respect to the transcriptional relationship
between CR and aging. In particular, among genes
involved in immune response, innate immune response
and immune system processes, the effects of CR were neg-
atively associated with those of aging (Figure 11; r ≤ -
0.39). These results are in agreement with the RT-PCR
investigation of Park et al. (2009) [11], which found that,
in heart and cerebellum, CR opposed the effects of aging
for certain genes associated with immunity and defense
response (e.g., C4, C1qa, Lzp-s, Cxcl14). Figures 11 and 12
also show that CR opposes age-associated expression pat-
terns among other classes of genes as well, such as groups
of genes with roles in apoptosis, protein amino acid
dephosphorylation, lipid transport, chemotaxis, biopoly-
mer metabolic process and inflammation. At the same
time, for some processes, the opposite pattern of associa-
tion was found (e.g., negative regulation of RNA meta-
bolic process; Figure 12), and for many gene groups, the
association between CR and aging was non-significant
and weakly inverse, in agreement with analyses based
upon global transcriptional patterns among all genes.
Discussion
Caloric restriction (CR) and aging have been found to
influence the expression of numerous genes in a variety of
mouse tissues, but there has been considerable heteroge-
neity in results generated from different laboratories. This
study has identified genes and gene expression modules
that, based upon currently available data, are most
robustly associated with CR and/or aging in the labora-
tory mouse. These transcriptional effects provide a well-
supported basis for the generation of new research
hypotheses, which can serve as starting points for experi-
mental studies into mechanisms of CR and aging. The
identified expression patterns influence a wide range of
tissue and cell types, and thus represent the most systemic
transcriptional effects of CR and aging, which may be
associated with pathways required for positive effects of
CR on survivorship, or linked to mechanisms that drive
increased disease and mortality risk with age. These tran-
scriptional effects were often modular, with groups of co-
expressed genes responding to CR or aging in coordina-
tion across multiple tissues. For instance, the analysis
uncovered a CR-responsive group of co-expressed genes
encoding histone clusters (Hist2h3c1,  Hist2h3c2,
Hist1h2bc,  Hist2h2aa1and  Hist1h1c), as well as a large
module that contains genes involved in mRNA processing
(e.g., Sfrs18, Sfpq, Prpf4b, Prpf39). Age-related expression
patterns affecting multiple tissues were, to a considerable
Relationship between caloric restriction and aging. Gene  ontology biological process terms associated with genes up  regulated by aging across all mouse tissues Figure 11
Relationship between caloric restriction and aging. 
Gene ontology biological process terms associated 
with genes up regulated by aging across all mouse tis-
sues. A total of 2554 genes were identified as significantly 
increased by aging across the 22 mouse tissue types, based 
upon stringent significance criteria (Pu < 0.001 and up regu-
lated by age in at least five mouse tissues). Among these 
genes, significantly over-represented gene ontology (GO) 
biological process terms were identified (P < 0.05; hypergeo-
metric test). These significant GO terms are shown in the 
chart and have been clustered according to the number of 
ancestor terms shared between any two GO biological proc-
esses. For each term, a subset of n associated genes was 
identified, and among these n genes, the correlation (r) 
between the transcriptional effects of CR and aging was eval-
uated. Transcriptional effects of CR and aging across tissues 
were defined as explained in Figure 7. For terms displayed in 
red font, the transcriptional association between CR and 
aging was negative (r < 0) and significant (P < 0.05). For terms 
displayed in blue font, the transcriptional association 
between CR and aging effects was positive (r > 0) and signifi-
cant (P < 0.05). For all other terms (black font), there was no 
significant relationship between transcriptional effects of CR 
and aging (P > 0.05).
cellular process (r = −0.071, n = 1348)
immune system process (r = −0.43, n = 275)
response to chemical stimulus (r = −0.056, n = 207)
response to other organism (r = −0.061, n = 50)
response to stress (r = 0.015, n = 431)
chemotaxis (r = −0.27, n = 81)
locomotory behavior (r = −0.15, n = 99)
immune response (r = −0.39, n = 288)
response to oxidative stress (r = 0.17, n = 49)
inflammatory response (r = −0.26, n = 144)
innate immune response (r = −0.42, n = 73)
hemopoietic or lymphoid organ development (r = 0.018, n = 82)
blood vessel development (r = 0.17, n = 53)
angiogenesis (r = −0.066, n = 139)
protein localization (r = 0.028, n = 59)
protein transport (r = −0.053, n = 512)
lipid transport (r = −0.29, n = 66)
endocytosis (r = −0.092, n = 143)
cytoskeleton−dependent intracellular transport (r = −0.18, n = 72)
regulation of biological quality (r = 0.21, n = 103)
cellular catabolic process (r = −0.19, n = 53)
monocarboxylic acid metabolic process (r = −0.081, n = 85)
phosphate metabolic process (r = −0.1, n = 86)
translation (r = −0.025, n = 298)
protein modification process (r = 0.0019, n = 196)
protein amino acid phosphorylation (r = −0.057, n = 580)
protein amino acid dephosphorylation (r = −0.23, n = 94)
cellular lipid metabolic process (r = −0.029, n = 124)
fatty acid biosynthetic process (r = −0.058, n = 53)
protein metabolic process (r = 0.0023, n = 118)
lipid catabolic process (r = −0.021, n = 80)
cell proliferation (r = −0.0021, n = 395)
cell communication (r = −0.026, n = 881)
actin cytoskeleton organization and biogenesis (r = −0.018, n = 107)
organelle organization and biogenesis (r = 0.039, n = 166)
T cell proliferation (r = −0.13, n = 53)
apoptosis (r = −0.14, n = 504)
regulation of cell proliferation (r = 0.0086, n = 262)
regulation of cell adhesion (r = −0.21, n = 42)
regulation of programmed cell death (r = −0.21, n = 104)
negative regulation of apoptosis (r = −0.012, n = 164)
positive regulation of apoptosis (r = −0.067, n = 133)
positive regulation of cell differentiation (r = −0.13, n = 47)
regulation of cell shape (r = 0.31, n = 44)
regulation of signal transduction (r = −0.1, n = 121)
cytokine and chemokine mediated signaling pathway (r = −0.25, n = 44)
intracellular signaling cascade (r = −0.044, n = 465)
protein kinase cascade (r = 0.0052, n = 100)
Ras protein signal transduction (r = −0.15, n = 55)
regulation of Rho protein signal transduction (r = −0.14, n = 62)
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degree, explained by the modularity of the transcriptome.
This was best demonstrated by a large module containing
40 inflammation and immune response genes (e.g., C1qa,
C1qb, C1qc, Cd48, Cd52 and Cd53), nearly all of which
increased expression with age in ten mouse tissues. It was
expected that effects of CR and aging would be associated,
with CR acting of oppose age-related changes in gene
expression. This was the case among genes associated with
certain biological processes (e.g., immune response and
inflammation), but at the genome-wide level among all
genes, the transcriptional association between CR and
aging was limited.
Common responses to CR represent systemic effects of
low-calorie diets that influence multiple organ systems
[12]. A previous study found that CR increased expression
of genes encoding the anti-oxidant metallothioneins (Mt1
and Mt2), the NF-kB inhibitor IkBa (Nfkbia), as well as
the tumor suppressor P21 (Cdkn1a) [12]. The present
investigation has revealed that these effects are even more
widespread than previously thought, each occurring in at
least seven mouse tissues (Additional File 5). Addition-
ally, widespread transcriptional effects of CR were identi-
fied that could influence the predisposition of mice to
develop cancers, which is thought to be a main factor
underlying pro-longevity effects of the CR diet [35,36].
These expression patterns were associated with a broad
range of tissue types, and include increased expression of
thioredoxin interacting protein (Txnip/Vdup1), zinc finger
and BTB domain containing 16 (Zbtb16/PLZF) and tissue
Relationship between caloric restriction and aging. Gene ontology biological process terms associated with genes down regu- lated by aging across all mouse tissues Figure 12
Relationship between caloric restriction and aging. Gene ontology biological process terms associated with 
genes down regulated by aging across all mouse tissues. A total of 663 genes were identified as significantly down reg-
ulated by aging across the 22 mouse tissue types, based upon stringent significance criteria (Pd < 0.01 and down regulated by 
age in at least five mouse tissues). Among these genes, significantly over-represented gene ontology biological process terms 
were identified (P < 0.05; hypergeometric test), and these terms are displayed in the figure. The same analysis described in Fig-
ure 11 was applied to each term. Colors indicate whether, among genes associated with each term, there was a significant neg-
ative relationship between transcriptional effects of CR and aging (red font; r < 0; P < 0.05), a significant positive relationship 
(blue font; r > 0; P < 0.05), or no significant relationship (black font; P > 0.05).
in utero embryonic development (r = 0.17, n = 142)
developmental process (r = −0.072, n = 912)
metabolic process (r = 0.048, n = 987)
cellular component organization and biogenesis (r = 0.08, n = 41)
gene expression (r = −0.019, n = 1752)
chromosome organization and biogenesis (r = 0.1, n = 35)
chromatin modification (r = −0.1, n = 149)
biosynthetic process (r = 0.11, n = 155)
biopolymer metabolic process (r = −0.36, n = 32)
enzyme linked receptor protein signaling pathway (r = 0.097, n = 90)
regulation of gene expression (r = −0.011, n = 490)
negative regulation of gene expression (r = 0.12, n = 67)
protein metabolic process (r = 0.0023, n = 118)
phosphate metabolic process (r = −0.1, n = 86)
regulation of macromolecule biosynthetic process (r = −0.039, n = 498)
cellular macromolecule metabolic process (r = 0.038, n = 36)
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (r = −0.048, n = 1504)
protein folding (r = 0.31, n = 102)
protein modification process (r = 0.0019, n = 196)
protein amino acid phosphorylation (r = −0.057, n = 580)
mRNA processing (r = −0.11, n = 228)
RNA splicing (r = −0.13, n = 172)
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (r = −0.0039, n = 447)
negative regulation of RNA metabolic process (r = 0.33, n = 48)
positive regulation of RNA metabolic process (r = 0.072, n = 60)
positive regulation of transcription from RNA polymerase II promoter (r = 0.015, n = 276)
positive regulation of transcription (r = −0.018, n = 123)
regulation of transcription, DNA−dependent (r = −0.03, n = 1568)
negative regulation of transcription from RNA polymerase II promoter (r = 0.018, n = 182)
transcription (r = −0.035, n = 1571)
DNA replication (r = 0.036, n = 108)
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inhibitor of metalloproteinase 3 (Timp3) (see Figure 2 and
Additional File 5). Furthermore, CR reduced expression of
thymosin (Tmsb10), secreted acidic cysteine rich glycopro-
tein (Sparc) and heat shock protein 1 (Hspb1) (see Figure
2), and each of these effects could also inhibit transforma-
tion or cellular proliferation and migration [37-40].
Increased expression of Txnip and Zbtb16 expression by
CR could reflect an anti-proliferative effect of low calorie
diets on a common pathway, since Txnip encodes a pro-
tein known to induce expression of Zbtb16 [41], and both
genes encode proteins that can promote apoptosis or limit
the invasive capacity of tumor cells [28,41,42]. Wide-
spread effects of CR on Txnip expression are especially
noteworthy, since Txnip-deficient mice exhibit several
abnormal responses to fasting [43], and because Txnip
can regulate activation of the PTEN tumor suppressor pro-
tein (also elevated by CR; see Figure 3) [44]. Like Txnip
and Zbtb16, Timp3 has tumor-suppressive properties [45],
and its expression limits tumor invasiveness and has been
correlated with survivorship in cancer patients [46,47].
Additionally, expression of Timp3  negatively controls
tumor necrosis factor alpha (TNF-a) levels, leading to
reduced NF-kB activation and inflammation [48,49].
Taken together, these results begin to outline a general-
ized response of the mammalian cell to CR. This response
involves increased expression of genes with tumor-sup-
pressive properties (e.g., Txnip,  Zbtb16,  Timp3  and
Cdkn1a), decreased expression of genes associated with
cellular transformation and proliferation (e.g., Tmsb10,
Sparc and Hspb1), as well as the induction of genes with
anti-inflammatory (e.g., Nfkbia, Timp3) or anti-oxidative
effects (e.g., Mt1, Mt2).
The beneficial effects of CR on survivorship may be
related to loss of insulin-like growth factor 1 (IGF-1) sign-
aling [50]. This type of mechanism has been shown to
increase lifespan and decrease cancer incidence in mutant
dwarf mice, in which serum IGF-1 levels are greatly dimin-
ished [24], or in which the localized bioavailability of
IGF-1 within tissues is reduced [51]. Similarly, it was
recently shown that mouse lifespan can be increased by
late-life administration of rapamycin, which inhibits
mTOR, an element downstream of the IGF-1/PI3-K path-
way [52]. A major question in aging biology, therefore, is
whether pro-survival effects of the CR diet are dependent
upon inhibition of IGF-1 signals in a manner that, to
some degree, parallels mechanisms underlying increased
lifespan in long-lived dwarf mutants and/or mice treated
with rapamycin. Along these lines, it is interesting to note
that the most widespread effect of CR to emerge from this
analysis was increased expression of serum/glucocorticoid
regulated kinase 1 (Sgk1), which occurred in 11 of the 17
mouse tissues examined (Figure 2A). The Sgk1 kinase is
activated by IGF-1/phosphatidylinositol-3 kinase (PI3-K)
signals, and data from several microarray analyses indi-
cate that expression of Sgk1 is up regulated by mutations
and treatments that inhibit the IGF-1/PI3-K pathway [53-
56]. Another widespread effect of CR was increased
expression of phosphatase and tensin homolog (Pten)
(Figure 4), which is a tumor suppressor that inhibits IGF-
1 signals by preventing activation of the PI3K/Akt signal-
ing pathway [57]. These effects of CR on Sgk1 and Pten
expression may reflect attenuation of IGF-1 signals across
a number of tissue types, possibly in a manner that, to
some degree, mimics the influence of dwarf longevity
mutations or rapamycin treatment. Such expression pat-
terns thus raise new questions for further work, which can
contribute to a developing model of interactions between
CR and the IGF-1 pathway [50].
The metabolism of mRNA is a fundamental process that
underlies virtually all cellular activities, and perturbation
of mRNA processing can have important effects on gene
regulation, homeostasis and cell cycle control. This study
has found that, in multiple tissues, CR influences the
expression of genes involved in the splicing and process-
ing of messenger RNA (Figure 3). These genes are co-
expressed and organized into a single large module that
includes splicing factors (Sf3b1, Sfpq, Sfrs18), pre-mRNA
processing factors (Prpf4b,  Prpf39), pre-mRNA cleavage
factor I (Cpsf6), an RNA/DNA binding protein associated
with splicing regulation and mRNA stability (Tardbp)
[58], a co-activator of pre-mRNA splicing (Srrm2/
SRm300) [59], and a yeast homolog of Luc7p that associ-
ates with the spliceosomal subunit U1 snRNP (Luc7l2)
[60]. The possibility that nutrient signals, and in particu-
lar CR, can have important effects on mRNA processing is
consistent with previous investigations. For example, glu-
cose-6-phosphate dehydrogenase (G6PD) protein levels
and activity are positively regulated by intake of carbohy-
drates, but without any alteration in transcription rate of
the associated G6pdx  gene [61]. Carbohydrate intake
instead appears to increase the efficiency of splicing events
within the nucleus, leading to increased abundance of
mature mRNA transcript and G6PD protein [61]. Nutri-
tional regulation of mRNA processing has also been
reported for thyroid hormone responsive SPOT14
homolog (Thrsp) [62], as well as insulin-like growth factor
I (Igf1) [63]. These examples suggest that nutritional
effects on mRNA processing are not altogether unusual,
and that some widespread effects of CR could result from
an influence on the multi-step process by which mRNAs
proceed from transcription to translation. This effect of
CR may be consequential for disease processes, since pro-
teins that regulate splicing events can contribute to cell
growth and the proliferation of cancer cells [64-66]. It is
interesting to note that expression of genes associated
with mRNA processing, RNA transport or RNA localiza-
tion are decreased by aging in many tissues (e.g., Syncrip
and Sfrs7; Figure 5; Additional File 11). This consistentBMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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effect of aging contrasted with that of CR, which variably
influenced the expression of functionally similar genes,
promoting increased expression in some tissues (e.g.,
cochlea and hypothalamus) but decreased expression in
others (e.g., mammary gland and liver) (see Figure 3).
There is much evidence to suggest that certain mecha-
nisms of aging are conserved across species, with similar
pathways regulating life span and the progression of aging
in worms, flies and mammals [67]. This notion suggests
that there may exist common features of aging that are
evolutionarily conserved, which are reflected by age-
related patterns of gene expression that are shared among
mammalian cell types within diverse tissues. The present
study has identified robust age-related expression patterns
that appear to be characteristic of cells within many or
most mammalian tissues. It is not expected that all such
age-related expression patterns will be associated with del-
eterious pathologies, since some modifications of gene
expression with age are likely to reflect favorable compen-
satory mechanisms. Nevertheless, some age-regulated
genes identified in this analysis are known to modulate
inflammatory processes and contribute to cellular prolif-
eration. For instance, two widespread effects of aging were
up regulation of granulin (Grn) and secreted phosphopro-
tein 1 (Spp1) (see Figure 5). Increased expression of Grn
was in fact the most widespread effect of aging identified,
occurring in nearly all of the tissues examined (16 of 22).
Grn encodes the granulin protein (also referred to as pro-
granulin, granulin-epithelin precursor, proepithelin or
acrogranin), which can inhibit TNF-induced inflamma-
tory processes and promote vascularization necessary for
wound and tissue repair [68], but can also give rise to
cleavage products that stimulate cytokine secretion lead-
ing to the exacerbation of inflammatory processes [69].
Additionally, granulin has been identified as potent
growth factor that stimulates aggressive cell proliferation,
and in at least some cell lines, this mitogenic effect
depends upon the expression level of Grn [70]. Increased
expression of Spp1 with age was identified in 14 of 22
mouse tissue types, with the strongest increase observed
in the cerebellum. Spp1 encodes osteopontin, a protein
involved in localized recruitment of macrophages and in
the production of cytokines within certain immune cells,
which can contribute to a state of chronic inflammation
[71]. Osteopontin is also a regulator of tumor progression
and its abundance within tumors has emerged as an
impressive biomarker for numerous types of cancer [72].
Expression of osteopontin within tissues and in circula-
tion has also been associated with a wide range of other
conditions, including obesity, diabetes and cardiovascular
disease [73-75]. An important component of future work
will be RT-PCR investigation of Grn and Spp1 expression
patterns with age, both across mouse tissues and among
different mouse strains [11].
A widespread effect of aging was increased expression of
inflammation and immune response genes, which
involved class I MHC genes (e.g., H2-D1, H2-K1), immu-
noglobulin chain components (e.g., Igk-V1, Igh-6), and a
large module of 40 co-expressed genes known to partici-
pate in inflammation and immune processes (see Figures
5 and 6; Additional File 10). These observations are con-
sistent with those from previous investigations that have
evaluated genome-wide expression patterns in aging mice
[30,31], and thus provide further evidence that height-
ened expression of inflammation and immune response
genes is a systemic feature of aging that influences a broad
range of organ systems. Indeed, exceptions to this pattern
may represent the most interesting cases. For example,
only 4 of 22 tissues did not show an age-related increase in
the expression of either H2-D1 or H2-K1 (adrenals, bone
marrow, gametes and gonads). It is likely that, at least in
part, increased expression of inflammation and immune
response genes reflects age-related increases in immune
cell populations within aging tissues. In liver, a recent his-
tological analysis demonstrated that several immune cell
types (i.e., macrophages, T and B cells, neutrophils and
natural killer cells) infiltrate perivascular regions with
aging to establish proliferating cell clusters [31]. This type
of mechanism is likely to explain, for example, the
increased expression of Igk-V1 and Igh-6 described in this
analysis, which could be driven by B-cell lymphocyte
infiltration of aging tissues. Such immune cell infiltration
could be driven by chronic inflammation, possibly in a
manner that parallels tertiary lymphoid neogenesis [76],
and it is further possible that such inflammation is exacer-
bated by an age-associated accumulation of fat cells [31].
An important direction for future studies will be to evalu-
ate mechanisms by which immune cells, such as lym-
phocytes, are drawn to aging tissues and whether such
mechanisms are comparable in various organ systems. An
inspection of current data, for example, revealed that the
B-cell attractants Ccl19 and Cxcl13 increase with age in
some tissues [31,77]. In particular, expression of Ccl19
increased with age in 5 tissues (cerebellum, eye, heart, kid-
ney and liver), while an age-related increase in Cxcl13
expression was observed in 8 tissues (aorta, cerebellum,
heart, kidney, lung, liver, muscle, whole brain).
The identification of robust age-related gene expression
patterns may lead to the development of useful "biomar-
kers", which could provide tools for tracking the progres-
sion of the aging in experimental studies [17].
Development of such indicators is requisite for making
objective statements regarding the effects of interventions,
or of particular mutations, on the deceleration (or acceler-
ation) of aging. The age-related expression patterns high-
lighted in this analysis represent systemic or near-systemic
effects, which have repeatedly emerged in multiple exper-
imental settings. Such transcriptional effects may thus beBMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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suitable for further evaluation as aging biomarkers, or as
components of a quantitative model whose output serves
as an aging biomarker [78]. The current data, for example,
suggest that increased expression of immune response
genes (e.g., H2-D1, H2-K1, Igk-V1 or Igh-6) is a reliable
feature of normal aging, perhaps representing a wide-
spread outcome of aging that compares with the promi-
nent but localized effects of aging in the thymus (i.e.,
thymic involution). Localized expression of such genes
may be either a cause of consequence of multiple age-
related pathologies [79,80], particularly if increased
expression arises from sustained inflammation in certain
tissues [31]. Consequently, such age-related effects may
provide informative endpoints that, in combination with
other indicators of aging and healthspan, will eventually
lead to surrogates for lifespan in experimental studies of
anti-aging interventions using the laboratory mouse [81].
In this sense, other aspects of the aging immune system
have also proven informative, such as T-cell subsets,
which have been found to predict mouse lifespan within
experimental cohorts [82-84]. Along these lines, extended
lifespan of mutant mice lacking the pregnancy-associated
plasma protein A (Pappa) gene is reflected by a delayed
rate of thymic atrophy [85].
A conceptual association between CR and aging has been
maintained for decades, and numerous investigations
have been designed around the expectation that CR inter-
feres with the progression of aging. The alternative view is
that CR and aging are in fact disparate phenomena, with
CR having many favorable phenotypic effects (e.g.,
decreased adipose tissue, improved insulin sensitivity,
increased survivorship), but not having effects broad
enough to be characterized in terms of the actual process
of "aging". Gene expression data is not, by itself, sufficient
to discriminate between these two views, and it is clear
that any sufficient definition of aging must include meas-
urements from multiple physiological domains [17].
Moreover, it is certainly possible that deleterious aspects
of aging are prevented by CR in ways that are not reflected
by gene expression patterns, and many age-associated
expression patterns may indeed reflect favorable compen-
satory mechanisms rather than pathological processes.
Nevertheless, gene expression data reflect the behavior of
numerous biochemical pathways, and such data are also
well-suited to quantitative investigation. Genome-wide
expression data can, in this regard, provide at least some
insight into the conceptual links between CR and aging.
There are elements of this analysis that support an associ-
ation between CR and aging, and elements that do not.
On the one hand, individual genes can be identified for
which the effects of CR oppose those of aging in multiple
tissues (e.g., Igh-6; see Figure 7), and this also appears to
be true among genes associated with certain types of bio-
logical processes (e.g., immune response, inflammation,
biopolymer metabolic process; see Figures 11 and 12). At
a global scale, however, among all genes, this association
is fairly weak. This is most clearly shown by the scatter-
plots in Figure 8, which indicate that genome-wide corre-
lations between CR and aging effects within particular
tissues do not exceed 0.10 in magnitude, and this basic
conclusion is supported by analyses shown in Figures 9
and 10. Among different tissues, the genome-wide associ-
ation was stronger in cardiac tissue, but weaker in liver,
muscle and central nervous system. Taken together, there-
fore, these analyses show that CR counters certain types of
age-associated expression patterns, but not others, with a
fairly weak global association among all genes, and some
degree of variability in the strength of the association
among mouse tissue types.
Conclusion
CR and aging have widespread biochemical effects and
systems-oriented approaches are needed to develop com-
prehensive in silico models that link these effects concep-
tually. Microarray analyses provide a data-driven
approach for judging which pathways serve as "hubs" that
connect the diverse processes modulated by CR and aging,
and this can lead to the construction of large gene interac-
tion networks, with scope substantially greater than those
generated by standard methods. This study has identified
sub-networks, embedded within the genome-wide tran-
scriptional network, that are responsive to either dietary
intake or aging across a variety of mouse tissues. CR influ-
enced small co-expression modules containing genes that
encode histone clusters (e.g., Hist2h3c1,  Hist2h3c2,
Hist1h2bc, Hist2h2aa1and Hist1h1c), period homologues
(Per1, Per2 and Per3), as well as a large module containing
genes involved in the splicing and processing of mRNA
(e.g., Sfrs18, Sfpq, Prpf4b, Prpf39). Aging increased expres-
sion of granulin (Grn) and secreted phosphoprotein 1
(Spp1) in more than 14 tissue types, and led to elevated
expression of genes and modules associated with inflam-
mation and immune response (e.g., H2-D1, H2-K1, Igk-V1
or  Igh-6). In general, many age-associated differential
expression patterns were explained by the underlying
modularity of the transcriptome. It was expected that the
transcriptional effects of CR and aging would be nega-
tively associated, and this was true for genes associated
with certain biological processes (e.g., immune response
and inflammation). At the genome-wide level, however,
CR and aging were found to have weak association, which
was stronger in heart relative to liver, muscle and central
nervous system.
Methods
Gene Expression Datasets
Gene expression datasets were obtained from the Gene
Expression Omnibus or ArrayExpress public databases
[86,87], or were received from contact authors of pub-BMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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lished studies upon request [23,88,89]. The analyzed data
represent a comprehensive collection of most or all exper-
iments that have evaluated the effects of CR and/or aging
in the laboratory mouse, including those generated as part
of the AGEMAP project [29]. Of 40 experiments that eval-
uated the effects of CR, 82% (33/40) were derived from
studies in which array data had been validated by RT-PCR
(Additional File 1). Of 67 experiments that evaluated the
effects of aging, 72% (48/67) were derived from studies in
which array data had been validated by RT-PCR (Addi-
tional File 1). The majority of experiments incorporated
into the analysis had thus been shown to generate reliable
results in agreement with PCR-based methods.
Most data were generated using Affymetrix oligonucle-
otide microarray platforms, but Illumina, Agilent or non-
commercial arrays were also used in some experiments
(Additional File 1). The general strategy followed in link-
ing all datasets was to assign transcripts to one or more
probe sets included on the Affymetrix 430 2.0 array. This
approach was taken because the 430 2.0 array, with more
than 39,000 transcripts, is the most comprehensive
mouse oligonucleotide array currently available. It was
therefore likely that transcripts represented on less com-
prehensive platforms would be a subset of those repre-
sented on the Affymetrix 430 2.0 array. Additionally,
comprehensive and updated annotation information was
available for the Affymetrix 430 2.0 array, and this plat-
form was also used to generate many of the datasets con-
sidered in the analysis. Data from early generation
Affymetrix platforms (e.g., MOE430, MG-U74, Mullk), or
from Illumina Mouseref arrays were linked to Affymetrix
430 2.0 identifiers according to best match tables pub-
lished by array manufacturers. For non-commercial
arrays, less annotation information was available, so best
match tables were generated from Unigene ids, Entrez ids,
or alignment scores between probe sequences. In a small
fraction of cases, multiple transcripts from one platform
corresponded with the same probeset on the Affymetrix
430 2.0 array, and no annotation was available to deter-
mine which transcript better matched the Affymetrix 430
2.0 array transcript. In these cases, the transcript associ-
ated with the most significant CR (or aging) effect was
selected, and the remaining (less significant) transcripts
were discarded from further analyses. This selection pro-
cedure ensured that significant results were not over-
looked, but may be regarded as non-conservative, because
tests used to select an appropriate transcript are not
accounted for when adjusting p-values to control the false
discovery rate among all genes included in the analysis
(described below). The number of excess tests performed
was small, however, and the significance of identified
genes is not altered when the false discovery rate is con-
trolled for a number of tests that greatly exceeds the
number of genes considered in the overall analysis. Meth-
ods for normalization and calculation of expression
scores varied, depending upon whether raw data was
available from corresponding authors. For Affymetrix
datasets in which CEL files were available, the gcRMA
algorithm was used for normalization and calculation of
expression scores. For other platforms, or when raw data
was not available, methods included RMA, average differ-
ence, quantile normalization, and calculation of Z-scores.
While these differences in pre-processing were not ideal,
the deleterious effect of such differences was minimized
by analyzing all experiments independently, without
combining expression scores from different studies (see
below).
Statistical Methods
Statistical methods for detection of differentially
expressed genes were similar to those described previously
[12]. For a small number of datasets, it was not possible
to obtain raw data for analysis. In these cases, the only
option was to generate differential expression signatures
based upon supplemental data files provided in original
research reports, in which significant CR and age-regu-
lated genes were identified based upon standard t-tests. In
most cases, however, raw data was available, and in these
instances, differential expression was evaluated based
upon linear model analysis. Most experiments utilized a
standard two-treatment design (e.g., CR versus ad lib, or
young versus old). To analyze these experiments, the
limma linear modeling package was used [90], which
bases statistical inference upon an empirical Bayes moder-
ated t-statistic. The denominator of this statistic is shrunk
towards a prior value that is set, in part, using information
borrowed across all transcripts, which stabilizes variance
estimates associated with individual genes [90]. For some
experiments, the design was more complex, and there
were additional experimental groups or covariates to be
taken account of (e.g., gender and age). For such experi-
ments, linear models included both gender, along with
age, in order to calculate a treatment effect adjusted for
these factors. For some aging experiments involving more
than just "young" and "old" treatments, the effect of age
was treated as a continuous factor embedded within a
standard regression model, along with any other poten-
tially relevant covariates (e.g., gender).
Fisher's method of p-value combination was used to inte-
grate differential expression results involving the same tis-
sue type, as well as results from different types of tissues
[91]. Given this meta-analytic approach, risk of false-pos-
itive identification is considerably reduced relative to that
associated with analysis of a single dataset [92]. For indi-
vidual tissues, p-values were integrated among i = 1,..., n
separate experiments using the statistic -2Σlog(Pi), which
has a c2 distribution with 2n degrees of freedom if each of
the n null hypotheses being considered is true. For someBMC Genomics 2009, 10:585 http://www.biomedcentral.com/1471-2164/10/585
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tissues, data from multiple experiments was not available
(Table 1) and it was therefore not necessary to apply
Fisher's method. Once p-values for each individual tissue
type had been obtained, the statistic -2Σlog(Pj) was used
to evaluate significance of expression patterns among the
j = 1,..., m tissues (m = 17 and 22 for the CR and aging
analyses, respectively). In applying Fisher's method, a
consideration was whether to combine p-values generated
by one-sided tests for up regulation, one-sided tests for
down regulation, or two-sided tests for either up or down
regulation. In some cases, the interest was to identify
genes consistently up regulated or down regulated, either
among replicate experiments evaluating the same tissue,
or among experiments evaluating different tissues (e.g.,
see Figures 2 and 5). For this purpose, Fisher's method was
applied to p-values generated from one-sided hypothesis
tests, where the Pi and Pj correspond to specific tests for an
expression shift in a particular direction (up or down). For
other analyses, the purpose was to extract differential
expression signatures for making comparisons among tis-
sues (e.g., Figures 1 and 4), or between the effects of CR
and aging (e.g., Figures 9 and 10). In these cases, Fisher's
method was used to calculate a one-sided p-value for up
regulation (Pu), as well as a one-sided p-value for down
regulation (Pd), and then the overall p-value was taken to
be the lower of these quantities, multiplied by a factor of
2 (i.e., 2 × min(Pu, Pd)) [29]. As an additional criterion, for
a transcript to be considered significantly up regulated, it
was required that Pd > 0.05. Likewise, for a transcript to be
considered significantly down regulated, it was required
that Pu > 0.05. Fisher's method assigns a disproportionate
weight to very small p-values, which can lead to a signifi-
cant overall p-value, even when most p-values being com-
bined suggest a weak treatment effect. To guard against
this possibility, p-values less than 10-3 were set equal to
10-3. This measure introduced a degree of conservatism in
results and ensured that p-values were not disproportion-
ately influenced by exceptionally low p-values associated
with certain experiments. As a final step, Fisher p-values
generated from the across-tissue meta-analysis were
adjusted for multiple testing using the Benjamini-Hoch-
berg method [93]. P-values generated by Fisher's method
that have been cited in text are therefore adjusted to
account for multiple hypothesis testing among all genes
considered in the analysis. Symbols corresponding to dif-
ferential expression results in Figures 2 -5, however, are
based upon comparison-wise type I error rates of 0.05
(i.e., symbols represent p-values that are not adjusted to
control the experiment-wise false discovery rate).
It was common for arrays to include multiple transcripts
annotated with the same gene symbol. To eliminate
redundancy in the results, and in comparisons among dif-
ferential expression signatures, it was necessary to pool
results among those transcripts associated with the same
gene symbol. This was done by selecting the transcript for
which effects of CR (or aging) were most significant. By
summarizing information in this fashion, a risk is that
alternative transcripts associated with the same gene sym-
bol could exhibit differential responses to CR or aging,
which might be overlooked. This was, however, unusual,
and in tissue-specific analyses (Additional Files 2, 3, 4, 7,
8 and 9), conflicts among multiple transcripts associated
with the same gene symbol are indicated. This procedure
led to a total of 21, 327 genes upon which most analyses
were based. The Affymetrix 430 2.0 array also included
5,794 transcripts that were not associated with any gene
symbol. These transcripts seldom had matches with tran-
scripts from other arrays, and were therefore often elimi-
nated from analyses. In this paper and in Additional data
files, such transcripts are identified based upon a Unigene
ID or an Affymetrix 430 2.0 probe set ID.
Distance between Differential Expression Signatures
The distance between differential expression signatures
was evaluated based upon adjusted residuals (e.g., see Fig-
ures 1, 4 and 7). In the analysis of contingency tables,
adjusted residuals reflect the magnitude of deviation from
expected cell counts, where expected cell counts are calcu-
lated under the assumption that the categorical variables
being cross-tabulated are independent. For a cell in row i
and column j, with observed cell count nij, and expected
cell count mij, the adjusted residual Rij is defined by Equa-
tion (1) [94].
The values pi+ and p+j represent marginal frequencies based
upon row and column totals of the contingency table. For
instance, if all cell counts sum to N, the value of pi+ is
, and the value of p+j is  . For large sam-
ples, adjusted residuals are expected to follow a standard
normal distribution, such that values greater than 3 in
absolute value are suggestive of a significant deviation
between observed and expected cell counts [94]. For a
comparison between two differential expression signa-
tures, a contingency table is formed that includes a total of
nine cells (see Figure 7), and for each cell, the adjusted
residual indicates whether there is an over or under-abun-
dance of genes within that particular category.
In Figures 1 and 4, a distance measure (d) was used to
compare differential signatures, where d is an element of
the interval [0, 1]. The value of d  is based upon two
adjusted residual values (R1 and R2). The value of R1 is the
adjusted residual associated with a contingency table cell
R
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that contains the number of genes up regulated by CR (or
aging) in both signatures. The value of R2 is the adjusted
residual associated with a cell containing the number of
genes down regulated by CR (or aging) in both signatures.
Since both R1 and R2, follow the standard normal distribu-
tion for large samples, the value of d was calculated by
applying the standard normal cumulative distribution
function, Φ(￿), to both R1 and R2.
The distance d is therefore the average of two p-values. The
first p-value, 1-Φ(R1), addresses whether there exists an
over-abundance of genes up regulated with respect to
both signatures, and the second p-value, 1-Φ(R2),
addresses whether there exists an under-abundance of
genes down regulated with respect to both signatures. Val-
ues of d less than 0.05 are therefore suggestive of non-ran-
dom associations between differential expression
signatures. This measure corresponded well with results
from significance tests of differential expression associa-
tion using methods that have been described previously
[24], based upon the binomial distribution approxima-
tion (Figures 1B and 4B; below-diagonal region).
Gene Co-Expression Patterns
The co-expression of genes was evaluated based upon pat-
terns across a large database of 3,700 Affymetrix 430 2.0
oligonucleotide arrays. These arrays included hybridiza-
tions from a wide range of RNA sources extracted in differ-
ent tissue types and under various experimental
conditions. This expression profiling approach has previ-
ously been used in mouse and other organisms to identify
co-expression patterns and to infer transcriptional net-
works [95-98], and several helpful reviews are available
that describe concepts and methodologies associated with
this systems-level approach [99,100]. To obtain the 3,700
arrays for expression profiling, an initial batch of 5,700
CEL files was downloaded from Gene Expression Omni-
bus, and each file was evaluated according to four quality
control criteria (average background, scale factor, percent
present, RNA degradation) [101]. The average back-
ground score provides an indication of the signal strength
associated with the lowest-intensity probes on each array.
It was desirable that all arrays used for expression profil-
ing have similar background scores, so background scores
were computed for all 5,700 arrays, and those with scores
below percentile 7.5 and above percentile 92.5 were elim-
inated. The scale factor is a measure of the global intensity
difference between a given array and a baseline target
intensity. To ensure that all arrays used for expression pro-
filing had similar scale factors, and thus similar overall
intensity, arrays with factors below percentile 7.5 and
above percentile 92.5 were removed from analyses. The
percent present refers to the percentage of probe sets on an
array for which intensity is sufficient to be called
"present", or expressed above background, by a detection
algorithm. Arrays with percent present calls below the
15th percentile were removed from analyses. Lastly, arrays
that potentially involved hybridization with low-quality
RNA were eliminated based upon a genome-wide RNA
degradation score. This score is calculated based upon the
degree of intensity difference between probes associated
with the 5' end of transcripts and probes associated with
the 3' end of transcripts. Arrays with degradation scores
above the 85th percentile were removed from the analysis.
After arrays had been filtered according to the above-
described quality control measures, there remained 3,700
arrays and these were used for expression profiling.
The 3,700 arrays were randomly assigned to 37 batches,
and for each batch separately, expression scores were cal-
culated using the RMA algorithm. The gcRMA algorithm
was not used, as in differential expression analyses (see
above), because a prior study has reported that gcRMA
normalization may lead to over-estimation of co-expres-
sion relationships [102]. This procedure generated a total
of 37 independent datasets, each with expression values
corresponding to 100 separate conditions. To evaluate the
co-expression of two transcripts, say X and Y, the Pearson
correlation coefficient (r) between X and Y was calculated
with respect to each of the 37 datasets individually, and
the 37 values of r were then averaged to generate a single
measure of co-expression between probe sets X and Y. For
all co-expression and network analyses (e.g., Figures 3 and
6), the distance between gene elements was based upon
the absolute value of the Pearson correlation coefficient
(i.e., 1 - |r|). All co-expression calculations were per-
formed after eliminating 4547 Affymetrix probe sets (10%
of those represented on the Affymetrix 430 2.0 Mouse
Genome Array), which were associated with identifiers
that included an "_s" or an "_x" suffix. Based upon probe
sequence information, such probe sets could cross-
hybridize with multiple transcripts from two separate
genes. It was therefore necessary to remove these probe
sets, prior to co-expression analyses, to ensure that some
co-expression estimates were not upwardly biased by
probe sets that cross-hybridize with multiple mRNA tran-
scripts in a non-specific fashion [103,104].
It was often necessary to evaluate the co-expression
between gene symbols or Unigene identifiers for which
there were multiple transcripts represented on the Affyme-
trix 430 2.0 array. As an illustrative example, suppose that
gene symbol X  is represented by transcripts x1 and  x2,
while gene symbol Y is represented by transcripts y1 and
y2. A summary distance measure was used for evaluating
the co-expression of X and Y, based on all combinations
of transcripts associated with X and Y. In this example,
d
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three values of r were calculated, one for the association
between x1 and y1, one for the association between x1 ver-
sus  y2, and one for x2 and  y2. The overall correlation
between X and Y was then taken as the single value of r
that was largest in absolute value. This approach was
applied for all such cases involving multiple transcripts
associated with a given gene symbol.
Co-expression modules of varying size (2, 3, 5, 10, 20 and
40 genes) were identified based upon the "nearest neigh-
bor" concept. In this approach, a co-expression module
was formed for each gene included in the analysis, by
identifying the 1 to 39 other genes with expression pat-
terns that were most similar. This led to a total of 21,327
co-expression modules, and as expected, there was some
degree of overlap in the composition of closely related
modules. After co-expression modules had been identi-
fied, each was scored to determine which was most
strongly associated with modified expression under CR or
aging. This was done using the statistic M, which is based
upon one-sided p-values used to test for up and downreg-
ulation of particular genes (Pu and Pd). For a module con-
taining i = 1,..., G genes, the M statistic integrated results
from significance analyses among j = 1,..., T tissue types in
a fashion similar to Fisher's method.
Large values of M suggest strong regulation of the module
by CR (or aging), whilesmaller values of M suggest weak
regulation of the module by CR (or aging). The value of M
for a given module is inversely related to the average value
of min(Pu, Pd) among the G genes included in a module.
The quantity min(Pu, Pd) is calculated for each gene
according to Equation (4), based upon T tissues for each
gene, where T may not be identical for all genes within a
module, since data was often not available for every tis-
sue. Because Equation (3) is scaled by the factor 1/G,
while Equation (4) is scaled by the factor (1/T), values of
M should be comparable among modules that differ in
size or in the number of tissue types for which data is
available. In general, however, the data suggested that M
decreased as module size increased.
The significance of the M values associated with each co-
expression module was assessed by simulation. The simu-
lation approach addressed whether co-expression patterns
contribute meaningful information, by evaluating
whether groups of transcripts formed using coexpression
patterns are, collectively, more responsive to CR or aging
than groups of transcripts that have been formed at ran-
dom. In each simulation trial, a total of N = 21,327 mod-
ules of size G were formed by randomly assigning G-1
transcripts to each of the N total transcripts, and calculat-
ing the value of M for each of the 1,..., N randomly gener-
ated modules. The maximum value of M  among all
21,327 randomly formed modules, referred to as M*, was
then determined. This process was repeated in 2,000 sim-
ulation trials, and for each trial, the value of M* was
recorded, providing a null distribution that reflected the
largest value of M  likely to arise among N  modules
formed randomly, without any reference to the observed
co-expression patterns. Observed values of M were then
compared to the M* null distribution in order to generate
p-values and evaluate the significance of individual co-
expression modules. The final step in the analysis was to
screen all modules, and retain those modules most
responsive to CR (or aging), while discarding less respon-
sive modules that overlapped with more highly ranked
modules. This was done by ranking all modules from
most to least responsive to CR (or aging) (i.e., rank mod-
ules by M), and discarding any module sharing at least
one gene with any more responsive module of higher
rank.
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